Zeo ScientifiX, Inc. (ZEOX) intrinsic value & 10-year financials
Zeo ScientifiX, Inc. (ZEOX) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 44.9% a year to $5.2M, with an average return on invested capital of 383.8%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.98
- Market cap
- $6.3M
- Revenue (FY2025)
- $5.2M
- Revenue growth (10-yr CAGR)
- 44.9%
- ROIC (10-yr avg)
- 383.8%
- Free cash flow (FY2025)
- -$741.0K
ZEOX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $5.2M | -$5.5M | -$0.86 | -$741.0K | -103.6% | 364.3% |
| FY2024 | $4.6M | -$4.7M | -$0.74 | — | -115.1% | 237.8% |
| FY2023 | $4.6M | -$7.0M | -$0.99 | -$2.2M | -148.5% | 413.5% |
| FY2022 | $6.5M | -$8.9M | -$1.56 | -$4.0M | -136.2% | 530.4% |
| FY2021 | $5.6M | -$12.8M | — | -$3.1M | -227.7% | 621.9% |
| FY2020 | $95.5K | -$12.6M | — | -$2.0M | -13030.2% | 745.2% |
| FY2019 | $71.7K | -$1.7M | — | -$598.2K | -2479.4% | 125.0% |
| FY2018 | $964.5K | -$3.5M | — | -$516.6K | -361.8% | 268.3% |
| FY2017 | $569.8K | -$9.0M | — | -$926.7K | -1516.5% | 398.2% |
| FY2016 | $184.9K | -$1.3M | — | -$574.5K | -564.3% | 133.2% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Zeo ScientifiX, Inc. is a consistent compounder, expanding top-line revenue at 44.9% annually over the past decade.
Zeo ScientifiX, Inc. has earned high returns on invested capital, averaging 29.4% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Zeo ScientifiX, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Zeo ScientifiX, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-28.57 per share.